GDI2 and hepatocellular carcinoma: The differential expression of GDI2 in gastric and hepatocellular carcinoma tissues provides potential insights for identifying biomarkers, predicting diagnosis, and assessing prognosis in gastric and hepatocellular carcinoma patients [9,23].